Roivant Sciences Ltd.

NasdaqGS:ROIV

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

Location

United Kingdom

Market Cap

USD 7.82 B

Share Price

USD 11.50

Avg Daily Volume

6,663,046

Change (1 day)

0.44%

Change (1 year)

7.58%

Change (YTD)

-2.79%

Roivant Sciences Ltd. EBIT for the Trailing 12 Months (TTM) ending March 31, 2025: USD -702.19 M

Roivant Sciences Ltd. EBIT is USD -702.19 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -115.40% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Roivant Sciences Ltd. EBIT for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 4.56 B.
Roivant Sciences Ltd. EBIT for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -995.22 M.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

NasdaqGS: ROIV

Roivant Sciences Ltd.

CEO	Mr. Matthew Gline
IPO Date	Dec. 8, 2020
Location	United Kingdom
Headquarters	11-12 St. James's Square
Employees	908
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💄 Cosmetics

Description

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Similar companies

AbbVie Inc.

USD 183.76

-0.83%

Novo Nordisk A/S

USD 69.76

-4.86%

Roche Holding AG

USD 339.66

0.85%

Abbott Laboratories

USD 133.26

0.20%

Novartis AG

USD 116.67

0.62%

AstraZeneca PLC

USD 140.89

0.81%

Merck & Co., Inc.

USD 80.16

1.39%

Amgen Inc.

USD 272.44

-5.84%

Pfizer Inc.

USD 24.03

0.25%

Gilead Sciences, Inc.

USD 106.19

-2.13%

Sanofi

USD 96.16

0.29%

Vertex Pharmaceuticals Incorporated

USD 443.54

0.61%

Bristol-Myers Squibb Company

USD 46.92

0.13%

Chugai Pharmaceutical Co., Ltd.

USD 51.71

0.69%

GSK plc

USD 18.97

0.58%

CSL Limited

USD 156.77

0.82%

MERCK Kommanditgesellschaft auf Aktien

USD 126.58

-0.39%

Regeneron Pharmaceuticals, Inc.

USD 511.92

0.43%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

0.15%

Takeda Pharmaceutical Company Limited

USD 29.87

1.96%

Alnylam Pharmaceuticals, Inc.

USD 313.13

1.11%

UCB SA

USD 190.31

4.88%

GE HealthCare Technologies Inc.

USD 71.16

-0.17%

Bayer AG

USD 30.38

-1.22%

Celltrion, Inc.

USD 118.44

2.18%

WuXi AppTec Co., Ltd.

USD 9.70

2.46%

Laboratory Corporation of America Holdings

USD 261.04

-0.32%

Hansoh Pharmaceutical Group Company Limited

USD 3.73

2.31%

Royalty Pharma plc

USD 35.40

1.55%

Insmed Incorporated

USD 105.42

2.67%

Regencell Bioscience Holdings Limited

USD 23.70

-37.65%

Biogen Inc.

USD 124.76

-1.80%

Astellas Pharma Inc.

USD 9.54

2.70%

Innovent Biologics, Inc.

USD 10.23

1.81%

Summit Therapeutics Inc.

USD 20.39

-0.83%

Shionogi & Co., Ltd.

USD 17.49

1.37%

Genmab A/S

USD 209.44

-1.30%

Neurocrine Biosciences, Inc.

USD 125.80

-0.59%

Torrent Pharmaceuticals Limited

USD 36.76

0.26%

Mankind Pharma Limited

USD 26.77

0.47%

Exelixis, Inc.

USD 43.37

7.43%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.75

0.99%

Ascendis Pharma A/S

USD 175.78

-0.63%

BioMarin Pharmaceutical Inc.

USD 54.08

-1.67%

Akeso, Inc.

USD 12.22

0.78%

Lupin Limited

USD 22.60

1.25%

Huadong Medicine Co., Ltd

USD 5.55

-4.21%

Ipsen S.A.

USD 116.69

0.38%

Swedish Orphan Biovitrum AB (publ)

USD 28.73

1.93%

StockViz Staff

June 24, 2025

Any question? Send us an email